AFME — Affluent Medical SAS Cashflow Statement
0.000.00%
Last trade - 00:00- €60.99m
- €77.00m
- €4.12m
Annual cashflow statement for Affluent Medical SAS, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | — | -14.8 | -15.2 | -15.7 | -14.7 |
| Depreciation | |||||
| Non-Cash Items | — | 1.29 | 1.11 | 0.975 | 0.864 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -8.94 | -1.17 | 0.684 | 0.18 | 0.141 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.94 | -12.4 | -11.1 | -12.1 | -11.3 |
| Capital Expenditures | — | -0.334 | -0.146 | -0.184 | -0.147 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.304 | 0.174 | 0 | 0 | -0.333 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.304 | -0.16 | -0.146 | -0.184 | -0.48 |
| Financing Cash Flow Items | 1.33 | 1.51 | -0.512 | 0.18 | -0.168 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12.8 | 18.3 | 2.4 | 11.3 | 11.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.52 | 5.76 | -8.83 | -0.922 | -0.434 |